Virological surveillance, molecular phylogeny, and evolutionary dynamics of hepatitis C virus subtypes 1a and 4a isolates in patients from Saudi Arabia-Reference-Cited by-同舟云学术

Virological surveillance, molecular phylogeny, and evolutionary dynamics of hepatitis C virus subtypes 1a and 4a isolates in patients from Saudi Arabia

Published:2021-03 Issue:3 Volume:28 Page:1664-1677
ISSN:1319-562X
Container-title:Saudi Journal of Biological Sciences
language:en
Short-container-title:Saudi Journal of Biological Sciences

Author:

AlMalki Waleed H.,Shahid Imran^ORCID,Abdalla Ashraf N.^ORCID,Johargy Ayman K.,Ahmed Muhammad^ORCID,Hassan Sajida

Publisher

Elsevier BV

Subject

General Agricultural and Biological Sciences

Reference45 articles.

1. HCV infection among Saudi population: high prevalence of genotype 4 and increased viral clearance rate;Abdel-Moneim;PLoS One,2012

2. Chronic hepatitis C in saudi arabia: three years local experience in a university hospital;Akbar;Hepat. Mon.,2012

3. Changing pattern of hepatitis viral infection in Saudi Arabia in the last two decades;Al-Faleh;Ann. Saudi. Med.,2003

4. al Nasser, M.N., 1992. 'Intrafamilial transmission of hepatitis C virus (HCV): a major mode of spread in the Saudi Arabia population'. Ann. Trop. Paediatr., 12: 211-5.

5. Inhibition of hepatitis C virus genotype 4 replication using siRNA targeted to the viral core region and the CD81 cellular receptor;Aljowaie;Cell Stress Chaperones,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computer-aided identification of dengue virus NS2B/NS3 protease inhibitors: an integrated molecular modelling approach for screening of phytochemicals;Journal of Biomolecular Structure and Dynamics;2023-09-25

2. Biologically Potent Benzimidazole-Based-Substituted Benzaldehyde Derivatives as Potent Inhibitors for Alzheimer’s Disease along with Molecular Docking Study;Pharmaceuticals;2023-01-30

3. HCV-Host Interactions: A Plethora of Genes and their Intricate Interplay Part 1: Virus Specific Factors;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01

4. Appling Drug Discovery in HCV-therapeutics: A snapshot from the past and glimpse into the future;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01

5. Real-World Therapeutic Outcomes of Direct-Acting Antiviral Regimens and Formidable Challenges;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01